Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant for Post-operative Nausea and Vomiting in Otologic Surgery
NCT07371728Phase 4Not yet recruiting
- Sponsor
- Jewish General Hospital
- Start
- Jun 2026
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aprepitant in Nausea and Vomiting, sponsored by Jewish General Hospital. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
aprepitant
03
Conditions
Nausea and Vomiting
Beyond the preview
Go deeper on NCT07371728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07371728.